Process analytical technology in the pharmaceutical industry: A toolkit for continuous improvement

PDA Journal of Pharmaceutical Science and Technology

Volumn 60, Issue 1, 2006, Pages 17-53

  Scott, Bradley ^a   Wilcock, Anne ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cost of quality; Multivariate tools; Near infrared spectroscopy; NIR; PAT; PAT benefits; PAT challenges; Pharmaceutical analysis; Pharmaceutical manufacturing; Pharmaceutical operations; Process analytical technology; Process analyzers; Quality; Review

Indexed keywords

7 AMINOCEPHALOSPORANIC ACID; ALPHA LACTOSE; AREMIS; BESITRAN; CHLORZOXAZONE; CODEINE PHOSPHATE; DICLOFENAC; ENALAPRIL MALEATE; ESCITALOPRAM; EXCIPIENT; FLUFENAMIC ACID; GEMFIBROZIL; KETOPROFEN; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; MIDECAMYCIN; MIOKAMYCIN; NIFEDIPINE; NIMESULIDE; PARACETAMOL; PHENAZONE; POLYCARBOPHIL; POLYMER; POVIDONE; SERTRALINE; STARCH; SUGAR; SULFAGUANIDINE; TESTOSTERONE; THEOPHYLLINE; UNINDEXED DRUG; VOLTAROL RETARD;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG MANUFACTURE; INFORMATION TECHNOLOGY; KNOWLEDGE MANAGEMENT; MULTIVARIATE ANALYSIS; NEAR INFRARED SPECTROSCOPY; PROCESS ANALYTICAL TECHNOLOGY; PROCESS CONTROL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REVIEW; STAFF TRAINING; TECHNOLOGY; VALIDATION PROCESS;

DATA INTERPRETATION, STATISTICAL; DRUG INDUSTRY; GUIDELINE ADHERENCE; GUIDELINES; GUIDELINES AS TOPIC; MULTIVARIATE ANALYSIS; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SYSTEMS INTEGRATION; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33144488961     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. PAT Guidance for Industry - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Office of Regulatory Affairs (ORA), Pharmaceutical cGMPs; September 2004.
2. Balboni, M. L. Process analytical technology: concepts and principles. Pharm. Technol. 2003, 27, 54.
3. Blumenstein, J. Pfizer. Regulatory Challenges: PAT Application in NDAs. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; June 12-13, 2002.
4. Clarke, P. E. CDER aims to improve drug manufacturing. News Along the Pike. Center for Drug Evaluation and Research 2002, 8 (July), 1.
5. Wechsler, J. Modernizing pharmaceutical manufacturing. Pharm. Technol. North America 2002, 26, 16-24.
6. Chrisholm, R. S. AstraZeneca. Perspective on Process and Analytical Validation. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
7. Dean, D. PriceWaterhouseCoopers. Pharma Manufacturing - Why There Is a Need to Improve. The Role of PAT. Presented at FDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
8. Hussain, A. S. Presented at PDA's Advisory Committee for Pharmaceutical Sciences (ACPS), The ACPS's Process Analytical Technology Subcommittee; Rockville, MD; November 28, 2001.
9. Hammond, S. Pfizer. Validation Perceptions That May Slow PAT Development and Implementation. Presented at Subcommittee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; October 23, 2002.
10. Laasonen, M.; Harmia-Pulkkinen, T.; Simard, C.; Räsänen, M.; Vuorela, H. Determination of the thickness of plastic sheets used in blister packaging by near infrared spectroscopy: Development and validation of the method. Eur. J. Pharm. Sci. 2004, 21, 493-500.
11. Han, S. M.; Faulkner, P. G. Determination of SB 216469-S during tablet production using near-infrared reflectance spectroscopy. J. Pharm. Biomed. Anal. 1996, 14, 1681-1689.
12. Andre, M. Multivariate analysis and classification of the chemical quality of 7-aminocephalosporanic acid using near-infrared reflectance spectroscopy. Anal. Chem. 2003, 75, 3460-3467.
13. Shah, D. N. Avenus Pharmaceuticals. Regulatory Challenges: Post-Approval PAT Applications. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; June 12-13, 2002.
14. Blanco, M.; Romero, M. A. Near-infrared libraries in the pharmaceutical industry: A solution for identity confirmation. Analyst 2001, 126, 2212-2217.
15. Lonardi, S.; Viviani, R.; Mosconi, L.; Bernuzzi, M.; Corti, P.; Dreassi, E.; Murratzu, C.; Corbini, G. Drug analysis by near-infra-red reflectance spectroscopy. Determination of the active ingredient and water content in antibiotic powders. J. Pharm. Biomed. Anal. 1989, 7, 303-308.
16. Plugge, W.; van der Vlies, C. Near-infrared spectroscopy as an alternative to assess compliance of ampicillin trihydrate with compendial specifications. J. Pharm. Biomed. Anal. 1993, 11, 435-442.
17. Hussain, A. S. Opening Remarks. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; June 12, 2002.
18. Avvallone, H. Johnson & Johnson. Development/Compliance Issues (Tablets). Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; June 12-13, 2002.
19. Hammond, S. Pfizer. Applications and Benefits of PAT. Presented at PDA's Advisory Committee For Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
20. Watson, D. J.; Dowdy, E. D.; DePue, J. S.; Kotnis, A. S.; Leung, S.; O'Reilly, B. C. Development of a safe and scalable oxidation process for the preparation of 6-hydroxybuspirone: Application of inline monitoring for process ruggedness and product quality. Org. Process Res. Dev., 2004, 8, 616-623.
21. Hussain, A. S. The Subcommittee on Process Analytical Technology (PAT): Overview and Objectives. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
22. Blanco, M.; Coello, J.; Iturriaga, H.; Maspoch, S.; de la Pezuela, C. Critical review: Near-infrared spectroscopy in the pharmaceutical industry. Analyst 1998, 123, 135R-150R.
23. Workman, Jr., J.; Veltkamp, D. J.; Doherty, S.; Anderson, B. B.; Creasy, K. E.; Koch, M.; Tatera, J. F.; Robinson, A. L.; Bond, L.; Burgess, L. W.; Bokerman, G. N.; Ullman, A. H.; Darsey, G. P.; Mozayeni, F.; Bamberger, J. A.; Greenwood, M. S. Process analytical chemistry. Anal. Chem. 1999, 71, 121R-180R.
24. Workman, Jr., J.; Creasy, K. E.; Doherty, S.; Bond, L.; Koch, M.; Ullman, A.; Veltkamp, D. J. Process analytical chemistry. Anal. Chem. 2001, 73, 2705-2718.
25. Blanco, M.; Villarroya, I. NIR spectroscopy: A rapid-response analytical tool. Trends Anal. Chem. 2002, 21, 240-250.
26. Lavine, B. K.; Workman, Jr., J. Chemometrics. Anal. Chem. 2002, 74, 2763-2770.
27. Workman, Jr., J.; Koch, M.; Veltkamp, D. J. Process analytical chemistry. Anal. Chem. 2003, 75, 2859-2876.
28. Yu, L. X.; Lionberger, R. A.; Raw, A. S.; D'Costa, R.; Wu, H.; Hussain, A. S. Applications of process analytical technology to crystallization processes. Adv. Drug Delivery Rev. 2004, 56, 349-369.
29. Shabushnig, J. G. Pharmacia Corporation. Process Analytical Technology: An Industry Perspective. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
30. Clevett, K. J. Process analytical chemistry-Industry perspectives-Trends in applications and technology. Process Control Qual. 1994, 6, 81-90.
31. Watano, S.; Numa, T.; Miyanami, K.; Osako, Y. A fuzzy control system of high shear granulation using image processing. Powder Technol. 2001, 115, 124-130.
32. Watano, S.; Numa, T.; Koizumi, I.; Osako, Y. Feedback control in high shear granulation of pharmaceutical powders. EJPB 2001, 52, 337-345.
33. Clarke, F. Extracting process-related information from pharmaceutical dosage forms using near infrared microscopy. Vib. Spectrosc. 2004, 34, 25-35.
34. Sinsheimer, J. E.; Poswalk, N. M. Pharmaceutical applications of the near infrared determination of water. J. Pharm. Sci. 1968, 57, 2007-2010.
35. Blanco, M.; Coello, J.; Iturriaga, H.; Maspoch, S.; Rovira, E. Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe. J. Pharm. Biomed. Anal. 1997, 16, 255-262.
36. Last, I. R.; Prebble, K. A. Suitability of near-infrared methods for the determination of moisture in a freeze-dried injection product containing different amounts of the active ingredient. J. Pharm. Biomed. Anal. 1993, 11, 1071-1076.
37. Rantanen, J.; Rasanen, E.; Tenhunen, J.; Kansakoski, M.; Mannermaa, J.; Yliruusi, J. In-line moisture measurement during granulation with a four-wavelength near infrared sensor: An evaluation of particle size and binder effects. EJPB 2000, 50, 271-276.
38. Rantanen, J.; Rasanen, E.; Antikainen, O.; Mannermaa, J.-P.; Yliruusi, J. In-line moisture measurement during granulation with a four-wavelength near-infrared sensor: An evaluation of process-related variables and a development of non-linear calibration model. Chemom. Intell. Lab. Syst. 2001, 56, 51-58.
39. Frake, P.; Greenhalgh, D.; Grierson, S. M.; Hempenstall, J. M.; Rudd, D. R. Process control and end-point determination of a fluid bed granulation by application of near infra-red spectroscopy. Int. J. Pharm. 1997, 151, 75-80.
40. Airaksinen, S.; Luukkonen, P.; Jorgensen, A.; Karjalainen, M.; Rantanen, J.; Yliruusi, J. Effects of excipients on hydrate formation in wet masses containing theophylline. J. Pharm. Sci. 2003, 92, 516-528.
41. Dyrby, M.; Engelsen, S. B.; Norgaard, L.; Bruhn, M.; Lundsberg-Nielsen, L. Chemometric quantitation of the active substance (containing C≡N) in a pharmaceutical tablet using near-infrared (NIR) transmittance and NIR FT-Raman spectra. Appl. Spectrosc. 2002, 56, 579-585.
42. Davis, T. D.; Morris, K. R.; Huang, H.; Peck, G. E.; Stowell, J. G.; Eisenhauer, B. J.; Hilden, J. L.; Gibson, D.; Byrn, S. R. In situ monitoring of wet granulation using online X-ray powder diffraction. Pharm. Res. 2003, 20, 1851-1857.
43. McCormick, D. PAT survey reflects optimism, uncertainty. Pharm. Technol. 2005, 29, 24.
44. Hussain, A. S. Second Meeting of FDA/ACPS Process Analytical Technology: Closing Remarks. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; June 12-13, 2002.
45. Neway, J. O. Filling the void: PAT in a connected manufacturing environment. Pharm. Technol. 2003, 27, 46-52.
46. Rudd, D. GlaxoSmithKline. Product and Process Development: An Industry Perspective. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
47. Hussain, A. S. Office of Pharmaceutical Sciences, CDER, FDA. ACPS Process Analytical Technology (PAT) Subcommittee Meeting #3 Opening Remarks. Presented at Subcommittee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; October 23, 2002.
48. Dubois, P.; Martinez, J.-R.; Levillain, P. Determination of five components in a pharmaceutical formulation using near infrared reflectance spectrophotometry. Analyst 1987, 112, 1675-1679.
49. Gold, T. B.; Buice Jr., R. G.; Lodder, R. A.; Digenis, G. A. Determination of extent of formaldehyde-induced crosslinking in hard gelatin capsules by near-infrared spectrophotometry. Pharm. Res. 1997, 14, 1046-1050.
50. Gupta, A.; Peck, G. E.; Miller, R. W.; Morris, K. R. Nondestructive measurements of the compact strength and the particle-size distribution after milling of roller compacted powders by near-infrared spectroscopy. J. Pharm. Sci. 2004, 93, 1047-1053.
51. Harris, S. C.; Walker, D. S. Quantitative real-time monitoring of dryer effluent using fiber optic near-infrared spectroscopy J. Pharm. Sci. 2000, 89, 1180-1186.
52. Kamat, M. S.; Lodder, R. A.; DeLuca, P. P. Near-infrared spectroscopic determination of residual moisture in lyophilized sucrose through intact glass vials. Pharm. Res. 1989, 6, 961-965.
53. Laasonen, M.; Harmia-Pulkkinen, T.; Simard, C.; Räsänen, M.; Vuorela, H. Development and validation of a near-infrared method for the quantitation of caffeine in intact single tablets. Anal. Chem. 2003, 75, 754-760.
54. Lonardi, S.; Newby, P. J.; Ribeiro, D.; Johnson, B. Why Does PAT Need Rapid Microbiology Methods? Presented at Subcommittee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; October 23, 2002.
55. O'Neil, A. J.; Jee, R. D.; Moffat, A. C. Measurement of the cumulative particle size distribution of microcrystalline cellulose using near infrared reflectance spectroscopy. Analyst 1999, 124, 33-36.
56. Otsuka, M. Comparative particle size determination of phenacetin bulk powder by using Kubelka-Munk Theory and principal component regression analysis based on near-Infrared spectroscopy. Powder Technol. 2004, 141, 244-250.
57. Sanchez, M. S.; Bertran, E.; Sarabia, L. A.; Ortiz, M. C.; Blanco, M.; Coello, J. Quality control decisions with near infrared data. Chemom. Intell. Lab. Sys. 2000, 53, 69-80.
58. Workman, J. Kimberly-Clark Corp. Chemometrics and PAT: An Opinion on Current Status and Recommendations for the Future. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
59. Herkert, T.; Prinz, H.; Kovar, K.-A. One hundred percent online identity check of pharmaceutical products by near-infrared spectroscopy on the packaging line. EJPB 2001, 51, 9-16.
60. Morisseau, K. M.; Rhodes, C. T. Near infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing. Pharm. Res. 1997, 14, 108-111.
61. Cui, X.; Zhang, Z.; Ren, Y.; Liu, S.; de B. Harrington, P. Quality control of the powder pharmaceutical samples of sulfaguanidine by using NIR reflectance spectrometry and temperature-constrained cascade correlation networks. Talanta 2004, 64, 943-948.
62. Woo, Y.-A.; Lim, H.-R.; Kim, H.-J.; Chung, H. Determination of hydrogen peroxide concentration in antiseptic solutions using a portable near-infrared system. J. Pharm. Biomed. Anal. 2003, 33, 1049-1057.
63. Abrahamsson, C.; Johansson, J.; Sparen, A.; Lindgren, F. Comparison of different variable selection methods conducted on NIR transmission measurements on intact tablets. Chemom. Intell. Lab. Sys. 2003, 69, 3-12.
64. Betz, G.; Bürgin, P. J.; Leuenberger, H. Power consumption measurement and temperature recording during granulation. Int. J. Pharm. 2004, 272, 137-149.
65. Blanco, M.; Eustaquio, A.; Gonzalez, J. M.; Serrano, D. Identification and quantitation assays for intact tablets of two related pharmaceutical preparations by reflectance near-infrared spectroscopy: Validation of the procedure. J. Pharm. Biomed. Anal. 2000, 22, 139-148.
66. Blanco, M.; Villar, A. Development and validation of a method for the polymorphic analysis of pharmaceutical preparations using near infrared spectroscopy. J. Pharm. Sci. 2003, 92, 823-820.
67. Yoon, W. L.; Jee, R. D.; Charvill, A.; Lee, G.; Moffat, A. C. Application of near-infrared spectroscopy to the determination of the sites of manufacture of proprietary products. J. Pharm. Biomed. Anal. 2004, 34, 933-944.
68. Blanco, M.; Romero, M. A.; Alcalà, M. Strategies for constructing the calibration set for a near infrared spectroscopic quantitation method. Talanta 2004, 64, 597-602.
69. Fountain, W.; Dumstorf, K.; Lowell, A. E.; Lodder, R. A.; Mumper, R. J. Near-infrared spectroscopy for the determination of testosterone in thin-film composites. J. Pharm. Biomed. Anal. 2003, 33, 181-189.
70. Jorgensen, A. N.; Luukkonen, P.; Rantanen, J.; Schaefer, T.; Juppo, A. M.; Yliruusi, J. Comparison of torque measurements and near-infrared spectroscopy in characterization of a wet granulation process. J. Pharm. Sci. 2004, 93, 2232-2243.
71. Laasonen, M.; Rantanen, J.; Harmia-Pulkkinen, T.; Michiels, E.; Hiltunen, R.; Räsänen, M.; Vuorela, H. Near infrared reflectance spectroscopy for the fast identification of PVC-based films. Analyst 2001, 126, 1122-1128.
72. Ritchie, G. E.; Roller, R. W.; Ciurczak, E. W.; Mark, H.; Tso, C.; MacDonald, S. A. Validation of a near-infrared transmission spectroscopic procedure. Part B: Application to alternate content uniformity and release assay methods for pharmaceutical solid dosage forms. J. Pharm. Biomed. Anal 2002, 29, 159-171.
73. Blanco, M.; Coello, J.; Iturriaga, H.; Maspoch, S.; de la Pezuela, C. Determination of absorbic acid in pharmaceutical preparations by near infrared reflectance spectroscopy. Talanta 1993, 40, 1671-1676.
74. Blanco, M.; Coello, J.; Iturriaga, H.; Maspoch, S.; de la Pezuela, C.; Russo, E. Control analysis of a pharmaceutical preparation by near-infrared reflectance spectroscopy. A comparative study of a spinning module and fibre optic probe. Anal. Chim. Acta 1994, 298, 183-191.
75. Gottfries, J.; Depui, H.; Fransson, M.; Jongeneelen, M.; Josefson, M.; Langkilde, F. W.; Witte, D. T. Vibrational spectrometry for the assessment of active substance in metoprolol tablets: A comparison between transmission and diffuse reflectance near-infrared spectrometry. J. Pharm. Biomed. Anal. 1996, 14, 1495-1503.
76. Higgins, J. P.; Arrivo, S. M.; Thurau, G.; Green, R. L.; Bowen, W.; Lange, A.; Templeton, A. C.; Thomas, D. L.; Reed, R. A. Spectroscopic approach for on-line monitoring of particle size during the processing of pharmaceutical nanoparticles. Anal. Chem. 2003, 75, 1777-1785.
77. Andersson, M.; Folestad, S.; Gottfries, J.; Johansson, M. O.; Josefson, M.; Wahlund, K.-G. Quantitative analysis of film coating in a fluidized bed process by in-line NIR spectrometry and multivariate batch calibration. Anal. Chem. 2000, 72, 2099-2108.
78. Broad, N. W.; Jee, R. D.; Moffat, A. C.; Eaves, M. J.; Mann, W. C.; Dziki, W. Non-invasive determination of ethanol, propylene glycol and water in a multi-component pharmaceutical oral liquid by direct measurement through amber plastic bottles using Fourier transform near-infrared spectroscopy. Analyst 2000, 125, 2054-2058.
79. Kirsch, J. D.; Drennen, J. K. Nondestructive tablet hardness testing by near-infrared spectroscopy: A new and robust spectral best-fit algorithm. J. Pharm. Biomed. Anal. 1999, 19, 351-362.
80. Eustaquio, A.; Blanco, M.; Jee, R. D.; Moffat, A. C. Determination of paracetamol in intact tablets by use of near infrared transmittance spectroscopy. Anal. Chim. Acta 1999, 383, 283-290.
81. Blanco, M.; Coello, J.; Eustaquio, A.; Iturriaga, H.; Maspoch, S. Analytical control of pharmaceutical production steps by near infrared reflectance spectroscopy. Anal. Chim. Acta 1999, 392, 237-246.
82. GlaxoSmithKline. Perspectives in Chemometrics. Presented at PDA's Advisory Committee for Pharmaceutical Sciences, Subcommittee on Process Analytical Technologies (PAT); Rockville, MD; February 25, 2002.
83. Bush, L. New CGMP plant at Purdue University offers multiple benefits. Pharm. Technol. 2003, 27, 22.